Pyxis Oncology
PYXS
PYXS
45 hedge funds and large institutions have $76.1M invested in Pyxis Oncology in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.
Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
14
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$11.6M |
| 2 |
2
Barclays
London,
United Kingdom
|
$3.84M |
| 3 |
TCM
3
Tekla Capital Management
Boston,
Massachusetts
|
$2.63M |
| 4 |
4
Citigroup
New York
|
$942K |
| 5 |
LCM
5
Laurion Capital Management
New York
|
$4.93M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GCM
51
Ghisallo Capital Management
Boston,
Massachusetts
| – | – | -30,000 | Closed |
|
52
Walleye Capital
New York
| – | – | -15,933 | Closed |
|
53
D.E. Shaw & Co
New York
| – | – | -10,367 | Closed |
|
54
Millennium Management
New York
| – | – | -10,253 | Closed |
|
|
DKCM
55
Davidson Kempner Capital Management
New York
| – | – | -10,000 | Closed |
|
|
SIM
56
Sandia Investment Management
Boston,
Massachusetts
| – | – | -10,000 | Closed |
|
|
CFGS
57
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|